Investor
The Series E funding comes four months after the company secured $250 million in a Series D round.
The partnership has been terminated less than two months after launch as Novo Nordisk alleges Hims & Hers is illegally selling copycat drugs and using deceptive marketing practices.
Julien Payen, cofounder and CEO of Lattice Medical, describes the company's 3D-printed, resorbable breast implant that uses a patient's own fat to regenerate natural breast tissue after a mastectomy.
Funding from the venture capital firm's Customer Value Fund will allow Commure to accelerate its expansion in healthcare without ownership dilution.
The funding comes on the heels of the fax automation company's $37 million Series B funding round and $18 million Series A raise last year.
In March, the company received FDA marketing authorization for the first at-home test to detect chlamydia, gonorrhea and trichomoniasis.
Lyrebird Health plans to scale its operation internationally, beginning in the United Kingdom.
The company's valuation has increased by $1 billion since its $130 million Series E funding round last year.
Nissan Elimelech, founder of Augmedics, discusses the process of developing augmented reality surgical navigation technology and his next endeavor to develop the first AR glasses specifically for healthcare.
Wojcicki, cofounder and former CEO of 23andMe, is set to reacquire the company through her nonprofit, TTAM Research Institute.